M

Marinus Pharmaceuticals
D

MRNS

0.32000
USD
0.01
(3.23%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-0
Market Cap
17,626,892
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BPMC
    -6.990
    (-7.31%)
    88.690 USD
    I
    INSM
    -4.950
    (-6.95%)
    66.310 USD
    K
    KPTI
    -0.02960
    (-3.54%)
    0.80740 USD
    P
    PTCT
    -3.110
    (-7.34%)
    39.270 USD
    S
    SAGE
    -0.26000
    (-4.84%)
    5.11000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Marinus Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.